» Articles » PMID: 23899749

The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping)

Overview
Journal Cerebrovasc Dis
Publisher Karger
Date 2013 Aug 1
PMID 23899749
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

ASCO phenotyping (A: atherosclerosis; S: small-vessel disease; C: cardiac pathology; O: other causes) assigns a degree of likelihood of causal relationship to every potential disease (1 for potentially causal, 2 for causality is uncertain, 3 for unlikely causal but the disease is present, 0 for absence of disease, and 9 for insufficient workup to rule out the disease) commonly encountered in ischemic stroke describing all underlying diseases in every patient. In this new evolution of ASCO called ASCOD, we have added a 'D' for dissection, recognizing that dissection is a very frequent disease in young stroke patients. We have also simplified the system by leaving out the 'levels of diagnostic evidence', which has been integrated into grades 9 and 0. Moreover, we have also changed the cutoff for significant carotid or intracranial stenosis from 70% to more commonly used 50% luminal stenosis, and added a cardiogenic stroke pattern using neuroimaging. ASCOD captures and weights the overlap between all underlying diseases present in ischemic stroke patients.

Citing Articles

Stroke etiology and white matter burden in women with and without migraine.

Wilms A, van der Weerd N, van Harten T, Linstra K, van Os H, de Boer I J Headache Pain. 2025; 26(1):37.

PMID: 39972322 PMC: 11841335. DOI: 10.1186/s10194-025-01975-8.


Neurological syndromes associated with COVID-19: a multicenter study in Brazil.

Matos A, Gomes A, Carvalho F, de Oliveira F, da Silva L, Dahy F BMC Infect Dis. 2025; 25(1):123.

PMID: 39871154 PMC: 11770952. DOI: 10.1186/s12879-025-10504-6.


Importance of infarct topography in determination of stroke mechanism and recurrence risk: a post-hoc analysis of the dabigatran acute treatment of stroke trial.

Cimen E, Ng K, Buck B, Field T, Coutts S, Gioia L BMJ Open. 2025; 15(1):e087704.

PMID: 39788764 PMC: 11751999. DOI: 10.1136/bmjopen-2024-087704.


Left ventricular disease as a risk factor for adverse outcomes and stroke recurrence in patients with embolic stroke of undetermined source.

Cascio Rizzo A, Schwarz G, Bonelli A, Magi A, Agostoni E, Moreo A Eur Stroke J. 2025; :23969873241311331.

PMID: 39754522 PMC: 11700389. DOI: 10.1177/23969873241311331.


Many strokes from a single non-stenosing plaque: from the last event a light to the first one?.

Zedde M, Pascarella R Neurol Sci. 2025; .

PMID: 39752008 DOI: 10.1007/s10072-024-07975-x.